Highlights Mass-spectrometry-based proteomic profiling of human cancers has the potential for pan-cancer analyses to identify molecular subtypes and associated pathway features that might be otherwise missed using transcriptomics Here, we classify 532 cancers, representing six tissue-based types (breast, colon,…
